Abstract

Despite the use of highly active antiretroviral therapy (HAART), neuronal cell death remains a problem that is frequently found in the brains of HIV-1-infected patients. HAART has successfully prevented many of the former end-stage complications of AIDS, however, with increased survival times, the prevalence of minor HIV-1 associated cognitive impairment appears to be rising among AIDS patients. Further, HIV-1 associated dementia (HAD) is still prevalent in treated patients as well as attenuated forms of HAD and CNS opportunistic disorders. HIV-associated cognitive impairment correlates with the increased presence in the CNS of activated, though not necessarily HIV-1-infected, microglia and CNS macrophages. This suggests that indirect mechanisms of neuronal injury and loss/death occur in HIV/AIDS as a basis for dementia since neurons are not themselves productively infected by HIV-1. In this review, we discussed the symptoms and causes leading to HAD. Outcome from this review will provide new information regarding mechanisms of neuronal loss in AIDS patients.

Highlights

  • Dementia cannot be considered as a disease by itself but it is the term used to describe a set of symptoms resulting from damages and disorders affecting the brain

  • Since many diseases and viral infection lead to dementia, we focused our review on human immunodeficiency virus type 1 (HIV-1) associated dementia, its symptoms and causes

  • The terms acquired immunodeficiency syndrome (AIDS) dementia complex (ADC), and HIV-1 associated dementia (HAD), are used to describe these neurological and psychiatric symptoms caused by HIV-1 infection [11,12]

Read more

Summary

Janssen RS

Epidemiology of human immunodeficiency virus infection and the neurologic complications of the infection. 8. McArthur JC, Sacktor N, Selnes O: Human immunodeficiency virus-associated dementia.

27. Bukrinskaya AG
30. Trkola A
35. Brack-Werner R: Astrocytes
37. Haase AT
46. Bomsel M
50. Dickson DW
Findings
98. Lipton SA
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call